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Metallopeptides for Enantioselective Catalysis
Gerard Roelfes*[a]
Metalloenzymes are the benchmark catalysts for efficient
enantioselective chemical transformations and, as such, are a
source of inspiration for catalyst design. As in transition metal
asymmetric catalysis, the first coordination sphere, that is, the
ligands provided by the protein that bind to the metal center
and tune its electronic properties, determine the catalytic
activity of metalloenzymes. However, the key to their high
efficiency and selectivity is the second coordination sphere; a
combination of additional interactions, such as hydrogen
bonding, electrostatic, hydrophobic, and steric interactions,
with the metal-bound substrate and/or activated complex.[1]
The increasing appreciation of the importance of second coor-
dination sphere interactions in catalysis has given rise to a new
approach to catalysis, which aims to create hybrid catalysts
that merge the catalytic power of transition metal complexes
with the high activities and enantioselectivities of metalloen-
zymes. To date, considerable effort has been devoted to the
design of artificial metalloenzymes; these are existing proteins
to which a transition metal complex is anchored in a covalent
or supramolecular fashion.[1,2] This research has given rise to a
number of highly enantioselective hybrid catalysts.[3] One of
the promises in this field yet to be fulfilled is that these
artificial metalloenzymes can be optimized further by using
the power of directed evolution methodologies.[4] However,
the technical challenges involved are formidable and, despite
some progress,[5] have still to be overcome.
An alternative approach to hybrid catalysts involves metallo-
peptides. The advantage of peptides is that they are readily
available and libraries can be prepared using the power of
parallel automated peptide synthesis. Whereas organocatalytic
peptides are abundant and have been demonstrated to give
high ee values and catalytic activities,[6] the field of metallopep-
tides for asymmetric catalysis has so far remained rather unex-
plored. The reported examples all include nonproteinogenic
metal-coordinating moieties, such as phosphines[7] and pyri-
dines,[8] as these generally provide superior metal coordination,
especially to late transition metals such as rhodium. Ball and
co-workers realized that the carboxylate-containing side chains
of proteinogenic amino acids such aspartate (Asp) and
glutamate (Glu) can be used to introduce a dirhodium tetracar-
boxylate complex into a helical peptide scaffold.[9] Dirhodium
tetracarboxylates are excellent catalysts for a wide variety of
enantioselective reactions, particularly those involving
carbenoid intermediates, such as cyclopropanations and XH
insertion reactions.[10] Sambasivan and Ball have now reported
the successful application of these dirhodium-containing pep-
tides in catalytic enantioselective SiH insertion reactions.[11]
Their first design involved a nonapeptide L1, with the
sequence KADAALDAK. The carboxylate moieties provided by
the aspartate side chains in the i and i+4 position, were used
as the bridging ligands to bind [Rh2(OAc)2] in a 1:1 peptide–
dirhodium complex [Rh2(OAc)2(L1)] . When applied to a bench-
mark SiH insertion reaction (Scheme 1), a modest but promis-
ing 32% ee was obtained for the reaction product. In a key
design step, the remaining acetate ligands were exchanged by
carboxylates from the peptide by forming a 2:1 peptide–dirho-
dium complex [Rh2(L1)2] , resulting in the formation of two iso-
meric metallopeptides, in which the two peptide strands had a
parallel or antiparallel orientation with respect to each other.
The two isomers, designated A and B, were separated, but it
has not been established which one is the parallel or the
antiparallel isomer. Both isomers were tested in catalysis and
gave rise to different enantioselectivities in the SiH insertion
reaction. Interestingly, the ee obtained with isomer B was
significantly higher than that obtained with [Rh2(OAc)2(L1)] .
Encouraged by these results, a small library of metallo-
peptides was prepared. Based on a previously computed struc-
ture,[12] positions i1 and i+3 were selected as positions for in-
troducing mutations, since their side chains are in proximity of
the metal centers. The screening of both the A and B isomers
of 22 metallopeptide variants identified several catalysts that
gave a high ee values in the benchmark reaction; up to 92%
ee was obtained when using the B isomer of the metallo-
peptide of L21 (Figure 1). Comparison of the sequence of the
metallopeptides giving the highest enantioselectivities re-
Scheme 1. Benchmark catalytic enantioselective SiH insertion reaction and
the two isomeric parallel and antiparallel metallopeptide catalysts [Rh2(L1)2]
(A and B isomers, arbitrary order). L1 is a nonapeptide with the sequence
KADAALDAK. The structures of the A and B isomers are not yet known.
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vealed some intriguing trends. Sterically demanding hydropho-
bic amino acids at position i+3 were found to give rise to the
best results. Particularly interesting, however, was the observa-
tion that threonine, asparagine, and tryptophan were the pre-
ferred residues at position i1. This finding suggests that, in
addition to steric interactions, other second coordination
sphere interactions with the bound substrate or activated com-
plex, such as hydrogen bonding, may also be important in ach-
ieving high enantioselectivity. Other findings indicated that the
nature and spacing of the metal-coordinating residues were of
particular importance. Inferior catalysts resulted from replacing
the metal-coordinating Asp residues with Glu, or from increas-
ing the distance between the metal-coordinating carboxylate
moieties.
The substrate scope of the catalytic asymmetric SiH inser-
tion reaction was investigated using isomer B of [Rh2(L21)2] ,
which gave the highest ee values in the benchmark reaction.
Excellent ee values were obtained by using a variety of aryl-
and vinyl-substituted diazoacetates; in the latter case, an ee of
97% was obtained. One example of an alkyl-substituted
diazoacetate was reported, which gave rise to lower
enantioselectivity.
Sambasivan and Ball have convincingly demonstrated the
potential of metallopeptides for enantioselective catalysis. An
open question remains the structure of the metallopeptide iso-
mers A and B, in particular whether the peptides are oriented
parallel or antiparallel, which will significantly change the cata-
lyst structure. Even though isomer B gave the highest ee in the
majority of cases, this was by no means a general trend. By
using the power of parallel automated peptide synthesis, it is
expected that this elegant and versatile strategy will give
access to new enantioselective catalytic reactions, including
transformations for which there is currently no alternative
using conventional asymmetric catalysis, thereby taking full
advantage of the readily tunable second coordination sphere.
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Figure 1. Optimization of the nonapeptide ligands L. Reprinted with per-
mission from reference [10] . Copyright 2010, American Chemical Society.
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